BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence

IAMJAN, Sri-arun, THANOI, Samur, WATIKTINKORN, Paritat, NUDMAMUD-THANOI, Sutisa and REYNOLDS, Gavin (2015). BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence. Pharmacogenomics, 16 (14), 1541-1545.

Full text not available from this repository.
Official URL:
Link to published version::


AIM: Association of the brain-derived neurotrophic factor (BDNF) genetic polymorphism rs6265 (Val66Met) with methamphetamine (METH) dependence and METH-induced psychosis was investigated in the Thai population. MATERIALS & METHODS: The rs6265 genotype was determined in 100 male METH-dependent subjects and 102 controls using a real-time PCR high-resolution melt (RT-PCR-HRM) assay. RESULTS: The rs6265 genotype demonstrated significant differences in distribution between METH-dependent subjects and controls in which the frequency of GG genotype versus A-allele carriers was associated with METH dependence. Moreover, a significant effect of genotype on the occurrence of psychosis was found, with a lower frequency of GG genotype associated with METH-induced psychosis. CONCLUSION: The present findings indicate that rs6265 is associated with METH dependence in the Thai population, with the GG genotype greater in METH-dependent subjects but reducing the emergence of METH-dependent psychosis.

Item Type: Article
Research Institute, Centre or Group - Does NOT include content added after October 2018: Biomedical Research Centre
Identification Number:
Page Range: 1541-1545
Depositing User: Margaret Boot
Date Deposited: 15 Aug 2016 08:37
Last Modified: 18 Mar 2021 18:07

Actions (login required)

View Item View Item


Downloads per month over past year

View more statistics